tiprankstipranks
The Fly

FDA authorization of ZYN pouches ‘slight positive’ for Philip Morris, says UBS

FDA authorization of ZYN pouches ‘slight positive’ for Philip Morris, says UBS

The FDA on Thursday authorized the marketing of 20 ZYN nicotine pouches, including flavors, which UBS tells investors is a “slight positive” for Philip Morris (PM), as the company is the first to receive approval for nicotine pouches and can continue to sell flavors. The firm, which has a Sell rating and $105 price target on the shares, says U.S. ZYN is 7% of fiscal 2024 EBIT.

Discover the Best Stocks and Maximize Your Portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1